JP2005532374A5 - - Google Patents

Download PDF

Info

Publication number
JP2005532374A5
JP2005532374A5 JP2004518242A JP2004518242A JP2005532374A5 JP 2005532374 A5 JP2005532374 A5 JP 2005532374A5 JP 2004518242 A JP2004518242 A JP 2004518242A JP 2004518242 A JP2004518242 A JP 2004518242A JP 2005532374 A5 JP2005532374 A5 JP 2005532374A5
Authority
JP
Japan
Prior art keywords
coating
coating suspension
osmopolymer
suspension
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004518242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005532374A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/021361 external-priority patent/WO2004002450A1/en
Publication of JP2005532374A publication Critical patent/JP2005532374A/ja
Publication of JP2005532374A5 publication Critical patent/JP2005532374A5/ja
Withdrawn legal-status Critical Current

Links

JP2004518242A 2002-06-28 2003-06-28 放出制御投薬形態物における発泡性浸透性組成物の形成のための(オスモポリマー、浸透剤を含んでなる)コーティング懸濁液ならびにこの浸透性コーティングを設けるための対応する方法 Withdrawn JP2005532374A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39277502P 2002-06-28 2002-06-28
PCT/US2003/021361 WO2004002450A1 (en) 2002-06-28 2003-06-28 Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating

Publications (2)

Publication Number Publication Date
JP2005532374A JP2005532374A (ja) 2005-10-27
JP2005532374A5 true JP2005532374A5 (OSRAM) 2006-08-03

Family

ID=30000934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004518242A Withdrawn JP2005532374A (ja) 2002-06-28 2003-06-28 放出制御投薬形態物における発泡性浸透性組成物の形成のための(オスモポリマー、浸透剤を含んでなる)コーティング懸濁液ならびにこの浸透性コーティングを設けるための対応する方法

Country Status (15)

Country Link
US (1) US7338663B2 (OSRAM)
EP (1) EP1528913A1 (OSRAM)
JP (1) JP2005532374A (OSRAM)
KR (1) KR20050071375A (OSRAM)
CN (1) CN1678292A (OSRAM)
AR (1) AR040301A1 (OSRAM)
AU (1) AU2003248868A1 (OSRAM)
CA (1) CA2490683A1 (OSRAM)
IL (1) IL165864A0 (OSRAM)
MX (1) MXPA05000207A (OSRAM)
NO (1) NO20050181L (OSRAM)
NZ (1) NZ537343A (OSRAM)
TW (1) TW200414900A (OSRAM)
WO (1) WO2004002450A1 (OSRAM)
ZA (1) ZA200500826B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
CA2578626C (en) * 2005-06-27 2011-07-19 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
CA2655596C (en) * 2006-06-27 2011-10-25 Biovail Laboratories International Srl Multiparticulate osmotic delivery system
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
US7785478B2 (en) * 2007-08-08 2010-08-31 General Electric Company Method for controlling protozoa that harbor bacteria
US8784659B2 (en) * 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
US20110052655A1 (en) * 2007-08-08 2011-03-03 Wilson Kurt Whitekettle Methods and vesicles for controlling protozoa
US7824557B2 (en) * 2007-08-08 2010-11-02 General Electric Company Method for controlling microbial biofilm in aqueous systems
CN102871982B (zh) 2012-10-16 2014-09-10 中国科学院上海药物研究所 一种药物渗透泵制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US36472A (en) * 1862-09-16 Cttlvebt
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5800422A (en) * 1995-06-02 1998-09-01 Alza Corporation Osmotic device with delayed activation of drug delivery and complete drug release
CN1161101C (zh) * 1998-12-17 2004-08-11 阿尔扎有限公司 用多层包衣将填充液体的明胶胶囊转变成控制释放的系统
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system

Similar Documents

Publication Publication Date Title
BE1001101A5 (fr) Forme de dosage pour le traitement des maladies cardiovasculaires.
JP4100910B2 (ja) ヒドロゲル駆動の薬物剤形
CA2307037C (en) Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
KR920008701B1 (ko) 비대칭막을 사용한 전달수단
FI110160B (fi) Molekyylipainoltaan erilaisia polymeerejä ja lääkeainetta sisältävän annosmuodon valmistusmenetelmä
JP2750150B2 (ja) 改良されたコアー膜付着性質を有する医薬的に許容される活性剤を含む浸透性連続分散性経口投写システム
HRP20030082A2 (en) Hydrogel-driven drug dosage form
US8173158B2 (en) Methods of treating gastrointestinal disorders independent of the intake of food
JPH08507087A (ja) 蒸気透過性コーチングを有する浸透デバイス
JP5425058B2 (ja) アルギン酸塩体を含む胃内滞留型システム
IT9020054A1 (OSRAM)
Wang et al. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects
JP2003513906A5 (OSRAM)
JP2005532374A5 (OSRAM)
RU2376983C2 (ru) Гастроретентивные композиции и способ их изготовления
US8956654B2 (en) Sustained release dosage form
PT1830855E (pt) Formas de apresentação farmacêuticas sólidas, para administração oral, contendo ritaroxaban com libertação modificada
Philip et al. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil
KR20130067255A (ko) 경구 투여 형태
CA3096919A1 (en) Composition of active ingredient loaded edible ink and methods of making suitable substrates for active ingredient printing on orodispersible films
Chauhan et al. Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: Optimization by central composite design
JP2024501051A (ja) 持続放出ウパダシチニブ配合物
JP2005518418A (ja) 浸透圧による送達システム
CN104873457A (zh) 缓释剂型
CN105012276A (zh) 一种咪达那新口腔速溶膜及其制备方法和用途